A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

NCT06006559 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Dengue

Interventions

DRUG: EYU688
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals